Journal
DIABETES
Volume 61, Issue 7, Pages 1734-1741Publisher
AMER DIABETES ASSOC
DOI: 10.2337/db11-1201
Keywords
-
Categories
Funding
- National Center for Global Health and Medicine [21A114]
- Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT)
- MEXT
- [19590338]
- [22510214]
Ask authors/readers for more resources
Potassium inwardly rectifying channel, subfamily J, member 15 (KCNJ15) is a type 2 diabetes associated risk gene, and Kcnj15 overexpression suppresses insulin secretion in rat insulinoma (INS1) cells. The aim of the current study was to characterize the role of Kenj15 by knockdown of this gene in vitro and in vivo. Human islet cells were used to determine the expression of KCNJ15. Expression of KCNJ15 mRNA in islets was higher in subjects with type 2 diabetes. In INS1 cells, Kenj15 expression was induced by high glucose containing medium. Regulation of Kcnj15 by glucose and its effect on insulin secretion were analyzed in INS1 cells and in normal mice and diabetic mice by the inactivation of Kcnj15 using small interfering RNA. Knockdown of Kcnj15 increased the insulin secretion in vitro and in vivo. KCNJ15 and Ca2+-sensing receptor (CsR) interact in the kidney. Binding of Kcnj15 with CsR was also detected in INS1 cells. In conclusion, downregulation of Kenj15 leads to increased insulin secretion in vitro and in vivo. The mechanism to regulate insulin secretion involves KCNJ15 and CsR. Diabetes 61:1734-1741,2012
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available